Cargando…

Predicting the diagnosis of prostate cancer with a scoring system based on novel biomarkers

OBJECTIVE: To predict prostate cancer using novel biomarker ratios and create a predictive scoring system. MATERIALS AND METHODS: Data of a total of 703 patients who consulted Urology Department of Selayang Hospital between January 2013 and December 2017 and underwent prostate biopsy were screened r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jethwani, Durvesh Lachman, Sivamoorthy, Lameena Lalitha, Toh, Charng Chee, Malek, Rohan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808971/ https://www.ncbi.nlm.nih.gov/pubmed/35109827 http://dx.doi.org/10.1186/s12894-022-00956-2

Ejemplares similares

Multiparametric transrectal ultrasound for the diagnosis of peripheral zone prostate cancer and clinically significant prostate cancer: novel scoring systems
por: Chen, Tong, et al.
Publicado: (2022)

Modified J‐CAPRA scoring system in predicting treatment outcomes of metastatic prostate cancer patients undergoing androgen deprivation therapy
por: Lim, Jasmine, et al.
Publicado: (2020)

Immune-related biomarker risk score predicts prognosis in prostate cancer
por: Liu, Zezhen, et al.
Publicado: (2020)

Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring System
por: Albitar, Maher, et al.
Publicado: (2016)

Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer
por: Zhang, Cuijian, et al.
Publicado: (2021)

Novel and Practical Scoring Systems for the Diagnosis of Thyroid Nodules
por: Wei, Ying, et al.
Publicado: (2016)

Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate Adenocarcinoma
por: Zhang, Lingyu, et al.
Publicado: (2021)

Emerging biomarkers in the diagnosis of prostate cancer
por: Filella, Xavier, et al.
Publicado: (2018)

Modern biomarkers in prostate cancer diagnosis
por: Porzycki, Paweł, et al.
Publicado: (2020)

Biomarkers of Aggressive Prostate Cancer at Diagnosis
por: Boehm, Brock E., et al.
Publicado: (2023)

Cardiovascular risk factors, ethnicity and infection stone are independent factors associated with reduced renal function in renal stone formers
por: Choy, Seow Huey, et al.
Publicado: (2022)

Prostate cancer in multi‐ethnic Asian men: Real‐world experience in the Malaysia Prostate Cancer (M‐CaP) Study
por: Lim, Jasmine, et al.
Publicado: (2021)

ARHGEF38 as a novel biomarker to predict aggressive prostate cancer
por: Liu, Kun, et al.
Publicado: (2019)

Biomarkers for Prostate Cancer: From Diagnosis to Treatment
por: Chen, Jia-Yan, et al.
Publicado: (2023)

Novel serum proteomic biomarkers for early diagnosis and aggressive grade identification of prostate cancer
por: Wang, Ce, et al.
Publicado: (2022)

A novel clinically significant prostate cancer prediction system with multiparametric MRI and PSA: P.Z.A. score
por: Chen, Zongxin, et al.
Publicado: (2023)

Prostate cancer polygenic risk score and prediction of lethal prostate cancer
por: Klein, Robert J., et al.
Publicado: (2022)

Novel magnetic resonance imaging scoring system for diagnosis of spinal tuberculosis
por: Zakham, Fathiah, et al.
Publicado: (2013)

Voice Biomarkers as Possible Indicators of Cognitive Aging
por: Mahon, Elizabeth, et al.
Publicado: (2021)

Novel diagnostic biomarkers for prostate cancer
por: Madu, Chikezie O., et al.
Publicado: (2010)

Novel biomarkers for the detection of prostate cancer
por: Jakobsen, Niels Asger, et al.
Publicado: (2016)

A Novel Nomogram Combined the Aggregate Index of Systemic Inflammation and PIRADS Score to Predict the Risk of Clinically Significant Prostate Cancer
por: Xie, Wenliang, et al.
Publicado: (2023)

Genetic Diagnosis of Familial Hypercholesterolemia in Asia
por: Huang, Chin-Chou, et al.
Publicado: (2020)

Hierarchical Ultrathin Layered GO-ZnO@CeO(2) Nanohybrids for Highly Efficient Methylene Blue Dye Degradation
por: Karpuraranjith, Marimuthu, et al.
Publicado: (2022)

Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome
por: Rysz, Jacek, et al.
Publicado: (2017)

Identification of Novel Diagnostic Biomarkers in Prostate Adenocarcinoma Based on the Stromal-Immune Score and Analysis of the WGCNA and ceRNA Network
por: Zhang, Tengfei, et al.
Publicado: (2022)

Assessing the validity of Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) scoring system in diagnosis of peripheral zone prostate cancer
por: Dola, Eman F., et al.
Publicado: (2017)

A scoring system based on novel biomarkers and clinical risk factors to predict invasive candidiasis in immunocompetent critically ill patients
por: Li, Wen, et al.
Publicado: (2023)

Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer
por: Lin, Jingwei, et al.
Publicado: (2023)

Combination of PI-RADS score and mRNA urine test—A novel scoring system for improved detection of prostate cancer
por: Katzendorn, Olga, et al.
Publicado: (2022)

Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development
por: Bahmad, Hisham F., et al.
Publicado: (2021)

tRNA-Derived RNA Fragments Are Novel Biomarkers for Diagnosis, Prognosis, and Tumor Subtypes in Prostate Cancer
por: Liu, Weigang, et al.
Publicado: (2023)

The function of oxytocin: a potential biomarker for prostate cancer diagnosis and promoter of prostate cancer
por: Xu, Huan, et al.
Publicado: (2017)

Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia
por: Jin, Wei, et al.
Publicado: (2020)

The Osaka prognostic score and Naples prognostic score: novel biomarkers for predicting short-term outcomes after spontaneous intracerebral hemorrhage
por: Liu, Rui, et al.
Publicado: (2023)

Noncoding RNAs as Novel Biomarkers in Prostate Cancer
por: Rönnau, C. G. H., et al.
Publicado: (2014)

A novel lysosome-related gene signature coupled with gleason score for prognosis prediction in prostate cancer
por: Huang, Ying, et al.
Publicado: (2023)

Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer
por: Klocker, Helmut, et al.
Publicado: (2020)

MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer
por: Bertoli, Gloria, et al.
Publicado: (2016)

Thiol Groups as a Biomarker for the Diagnosis and Prognosis of Prostate Cancer
por: Koike, Alexsandro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ujg1veqnopq4ffp14qoj4kr3bk